Free Trial
NYSE:IH

iHuman (IH) Stock Price, News & Analysis

iHuman logo
$2.77 -0.07 (-2.46%)
Closing price 03:58 PM Eastern
Extended Trading
$2.75 -0.02 (-0.72%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About iHuman Stock (NYSE:IH)

Key Stats

Today's Range
$2.63
$2.82
50-Day Range
$2.24
$3.16
52-Week Range
$1.47
$3.60
Volume
20,675 shs
Average Volume
31,974 shs
Market Capitalization
$144.10 million
P/E Ratio
10.26
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iHuman Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

IH MarketRank™: 

iHuman scored higher than 24% of companies evaluated by MarketBeat, and ranked 507th out of 590 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for iHuman.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of iHuman is 10.26, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 28.68.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of iHuman is 10.26, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 16.69.

  • Price to Book Value per Share Ratio

    iHuman has a P/B Ratio of 1.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about iHuman's valuation and earnings.
  • Percentage of Shares Shorted

    0.04% of the float of iHuman has been sold short.
  • Short Interest Ratio / Days to Cover

    iHuman has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iHuman has recently increased by 364.71%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    iHuman does not currently pay a dividend.

  • Dividend Growth

    iHuman does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.04% of the float of iHuman has been sold short.
  • Short Interest Ratio / Days to Cover

    iHuman has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in iHuman has recently increased by 364.71%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    iHuman has a news sentiment score of 0.48. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Consumer Discretionary companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for iHuman this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, iHuman insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.92% of the stock of iHuman is held by institutions.

  • Read more about iHuman's insider trading history.
Receive IH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter.

IH Stock News Headlines

Estimating The Intrinsic Value Of iHuman Inc. (NYSE:IH)
Get ready for a Ground Breaking alert Coming this Wednesday night!!!
Get ready for a Ground Breaking alert Coming this Wednesday night!!! Click the link below to sign up for TradingWire and get ready to have your MIND BLOWN!!!
iHuman (NYSE:IH) Might Have The Makings Of A Multi-Bagger
iHuman Inc. Files 2024 Annual Report on Form 20-F
See More Headlines

IH Stock Analysis - Frequently Asked Questions

iHuman's stock was trading at $1.69 at the start of the year. Since then, IH shares have increased by 63.9% and is now trading at $2.77.

iHuman Inc. Sponsored ADR (NYSE:IH) announced its quarterly earnings data on Thursday, June, 26th. The company reported $0.07 earnings per share for the quarter. The business earned $29 million during the quarter. iHuman had a trailing twelve-month return on equity of 11.00% and a net margin of 11.44%.

iHuman (IH) raised $84 million in an initial public offering (IPO) on Friday, October 9th 2020. The company issued 7,000,000 shares at a price of $11.00-$13.00 per share. Credit Suisse and Citigroup served as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers.

Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iHuman investors own include Chevron (CVX), Baidu (BIDU), Tencent Music Entertainment Group (TME), Alibaba Group (BABA), Exxon Mobil (XOM), Abbott Laboratories (ABT) and JD.com (JD).

Company Calendar

Last Earnings
6/26/2025
Today
8/18/2025
Next Earnings (Estimated)
9/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
SCHOOLS
Sub-Industry
Personal Services
Current Symbol
NYSE:IH
CIK
1814423
Fax
N/A
Employees
1,120
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$0.27
Trailing P/E Ratio
10.17
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$13.51 million
Net Margins
11.44%
Pretax Margin
11.99%
Return on Equity
11.00%
Return on Assets
7.38%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.07
Quick Ratio
3.02

Sales & Book Value

Annual Sales
$126.34 million
Price / Sales
1.13
Cash Flow
$0.29 per share
Price / Cash Flow
9.61
Book Value
$2.53 per share
Price / Book
1.08

Miscellaneous

Outstanding Shares
52,020,000
Free Float
18,934,000
Market Cap
$142.79 million
Optionable
Not Optionable
Beta
0.39

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NYSE:IH) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners